Ressources

Recherchez un centre participant à l’essai clinique AIRFLOW-3 ou recevez les dernières nouvelles sur Nuvaira et les mises à jour multimédia.

Rechercher un centre investigateur

Recherchez un centre près de chez vous qui dispose du traitement par le système de dénervation des poumons dNerva dans le cadre de l’essai clinique AIRFLOW-3.

Centres investigateurs en Europe

Autriche
Klinik Floridsdorf
Vienna, Autriche
France
CHU de la Cavale Blanche
Brest, France
CHU Grenoble-Alpes
Grenoble, France
CHU Arnaud de Villeneuve
Montpellier, France
CHU Pasteur
Nice, France
CHU Bichat-Claude Bernard
Paris, France
CHU Maison Blanche
Reims, France
Nouvel Hôpital Civil
Strasbourg, France
CHU Larrey
Toulouse, France
Allemagne
Thoraxklinik Universitätsklinikum Heidelberg
Heidelberg, Allemagne
Pays-Bas
University Medical Center Groningen
Groningen, Pays-Bas
Amsterdam UMC
Amsterdam, Pays-Bas
Royaume-Uni
Royal Brompton Hospital
Londres, Royaume-Uni

Centres investigateurs en États-Unis

Alabama
University of Alabama Lung Health Center
Birmingham, Alabama
Arizona
Honor Health
Birmingham, Alabama
California
UC Davis Health
Sacramento, CA
Harbor-UCLA Medical Center
Torrance, CA
Florida
Ascension St. Vincent’s
Jacksonville, FL
Illinois
The University of Chicago Medicine
Chicago, IL
AMITA Health Alexian Brothers Medical Center Elk Grove Village
Elk Grove Village, IL
Kentucky
University of Louisville Health
Louisville, KY
Ohio
The Ohio State University Wexner Medical Center
Columbus, OH
Michigan
University of Michigan Health
Ann Arbor, MI
Spectrum Health
Grand Rapids, MI
Massachusetts
Beth Israel Lahey Health
Burlington, MA
Missouri
Washington University Medical Center
St. Louis, MO
North Carolina
Duke University Medical Center
Durham, NC
Pennsylvania
Temple Health Lung Center
Philadelphia, PA
University of Pittsburgh Medical Center
Pittsburgh, PA
South Carolina
Medical University of South Carolina
Charleston, SC
Texas
Houston Methodist Hospital
Houston, TX
St. David’s Medical Center
Georgetown, TX

Contactez-nous pour en savoir plus sur le processus d’orientation des patients

Actualités et médias

Juin 10, 2019

First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

A first for Temple University Hospital and U.S. Patients MINNEAPOLIS, June 10, 2019 – Nuvaira, developer of novel therapeutic strategies to treat obstructive…

Mai 02, 2019

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2019 – Nuvaira, developer of novel therapeutic strategies to treat…

Fév 11, 2019

Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD

Market Development Veteran Lisa Rogan Joins Nuvaira’s Executive Team MINNEAPOLIS, Feb 11, 2019 – Nuvaira, a developer of novel therapeutic medical devices…

Références

Votre patient est-il est bon candidat pour l’essai AIRFLOW-3 ?